Argan (AGX) Common Equity (2011 - 2026)

Argan has disclosed Common Equity across 16 years of filings, most recently posting $506.8 million for Q3 2026.

• In Q3 2026, Common Equity rose 28.91% year-over-year to $506.8 million; the TTM figure through Jul 2026 stood at $506.8 million (up 28.91% YoY), while the FY2026 annual figure was $462.3 million, up 31.38% from the prior year.
• Common Equity came in at $506.8 million for Q3 2026 at Argan, up from $473.5 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $506.8 million in Q3 2026 to a low of $271.7 million in Q4 2022.
• Average Common Equity over 5 years is $342.0 million, with a median of $308.1 million recorded in 2024.
• Year-over-year, Common Equity decreased 22.31% in 2022 and jumped 31.38% in 2026.
• Over 5 years, Common Equity stood at $271.7 million in 2022, then climbed by 4.82% to $284.8 million in 2023, then advanced by 15.4% to $328.7 million in 2024, then gained by 27.69% to $419.7 million in 2025, then gained by 20.76% to $506.8 million in 2026.
• Per Business Quant data, the three most recent Common Equity figures were $506.8 million in Q3 2026, $473.5 million in Q2 2026, and $462.3 million in Q1 2026.